Trial ID or NCT#

NCT01833806

Status

NOT RECRUITING

Purpose

The study hypotheses is that the proportion of patients experiencing clinically significant pain relief will be at least 30% greater than the proportion experiencing worsening pain.

Official Title

A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Pejman Ghanouni, MD, PhD
Radiologist
Assistant Professor of Radiology (General Radiology) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Omar Rutledge
(650) 721-4089